234 related articles for article (PubMed ID: 26847292)
1. Retrospective Analysis on the Effects of House Dust Mite Specific Immunotherapy for More Than 3 Years in Atopic Dermatitis.
Lee J; Lee H; Noh S; Bae BG; Shin JU; Park CO; Lee KH
Yonsei Med J; 2016 Mar; 57(2):393-8. PubMed ID: 26847292
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multi-centre, randomized, dose-response study.
Werfel T; Breuer K; Ruéff F; Przybilla B; Worm M; Grewe M; Ruzicka T; Brehler R; Wolf H; Schnitker J; Kapp A
Allergy; 2006 Feb; 61(2):202-5. PubMed ID: 16409197
[TBL] [Abstract][Full Text] [Related]
3. Immunological changes after ASIT in AD allergen-specific immunotherapy and their potential correlation with clinical response in patients with atopic dermatitis patients sensitized to house dust mite.
Zhong H; Deng X; Song Z; Darsow U; Chen W; Chen S; Luo N; Hao F
J Eur Acad Dermatol Venereol; 2015 Jul; 29(7):1318-24. PubMed ID: 25376542
[TBL] [Abstract][Full Text] [Related]
4. Clinical improvement and immunological changes in atopic dermatitis patients undergoing subcutaneous immunotherapy with a house dust mite allergoid: a pilot study.
Bussmann C; Maintz L; Hart J; Allam JP; Vrtala S; Chen KW; Bieber T; Thomas WR; Valenta R; Zuberbier T; Sager A; Novak N
Clin Exp Allergy; 2007 Sep; 37(9):1277-85. PubMed ID: 17845407
[TBL] [Abstract][Full Text] [Related]
5. Clinical Efficacy of Subcutaneous Allergen Immunotherapy in Patients with Atopic Dermatitis.
Nahm DH; Kim ME; Kwon B; Cho SM; Ahn A
Yonsei Med J; 2016 Nov; 57(6):1420-6. PubMed ID: 27593870
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the long-term efficacy and safety of subcutaneous immunotherapy for atopic dermatitis.
Zhou J; Chen S; Song Z
Allergy Asthma Proc; 2021 Mar; 42(2):e47-e54. PubMed ID: 33685566
[No Abstract] [Full Text] [Related]
7. [Specific immunotherapy in the treatment of patients with atopic dermatitis--results of double blind placebo controlled study].
Silny W; Czarnecka-Operacz M
Pol Merkur Lekarski; 2006 Dec; 21(126):558-65. PubMed ID: 17405298
[TBL] [Abstract][Full Text] [Related]
8. Does allergen-specific immunotherapy represent a therapeutic option for patients with atopic dermatitis?
Bussmann C; Böckenhoff A; Henke H; Werfel T; Novak N
J Allergy Clin Immunol; 2006 Dec; 118(6):1292-8. PubMed ID: 17157659
[TBL] [Abstract][Full Text] [Related]
9. [Effect of 1-year specific immunotherapy with standardized house dust mite vaccine on mild to moderate allergic asthmatic patients].
Wang HY; Lin XP; Hao CL; Zhang CQ; Sun BQ; Zheng JP; Chen P; Sheng JY; Wu A; Zhong NS
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Oct; 29(10):679-87. PubMed ID: 17129496
[TBL] [Abstract][Full Text] [Related]
10. Specific immunotherapy in atopic dermatitis--Four-year treatment in different age and airborne allergy type subgroups.
Czarnecka-Operacz M; Silny W
Acta Dermatovenerol Croat; 2006; 14(4):230-240. PubMed ID: 17328144
[TBL] [Abstract][Full Text] [Related]
11. Allergen-specific immunotherapy for patients with atopic dermatitis sensitized to animal dander.
Chu H; Park KH; Kim SM; Lee JH; Park JW; Lee KH; Park CO
Immun Inflamm Dis; 2020 Jun; 8(2):165-169. PubMed ID: 32162849
[TBL] [Abstract][Full Text] [Related]
12. Safety of accelerated schedules of subcutaneous allergen immunotherapy with house dust mite extract in patients with atopic dermatitis.
Kim ME; Kim JE; Sung JM; Lee JW; Choi GS; Nahm DH
J Korean Med Sci; 2011 Sep; 26(9):1159-64. PubMed ID: 21935270
[TBL] [Abstract][Full Text] [Related]
13. Effect of Cluster Allergen-Specific Immunotherapy in Patients with Atopic Dermatitis Sensitive to House Dust Mite.
Elazab SZ; Hessam WF; Gomaa AH
Egypt J Immunol; 2018 Jun; 25(2):97-106. PubMed ID: 30600952
[TBL] [Abstract][Full Text] [Related]
14. Sublingual immunotherapy efficacy in patients with atopic dermatitis and house dust mites sensitivity: a prospective pilot study.
Cadario G; Galluccio AG; Pezza M; Appino A; Milani M; Pecora S; Mastrandrea F
Curr Med Res Opin; 2007 Oct; 23(10):2503-6. PubMed ID: 17784996
[TBL] [Abstract][Full Text] [Related]
15. Different Responses in Induction of Allergen Specific Immunoglobulin G4 and IgE-Blocking Factors for Three Mite Subcutaneous Immunotherapy Products.
Park KH; Lee SC; Son YW; Jeong KY; Shin YS; Shin JU; Sim da W; Park HJ; Lee JH; Lee KH; Park JW
Yonsei Med J; 2016 Nov; 57(6):1427-34. PubMed ID: 27593871
[TBL] [Abstract][Full Text] [Related]
16. The Effectiveness of Allergen Immunotherapy in Adult Patients with Atopic Dermatitis Allergic to House Dust Mites.
Bogacz-Piaseczyńska A; Bożek A
Medicina (Kaunas); 2022 Dec; 59(1):. PubMed ID: 36676639
[TBL] [Abstract][Full Text] [Related]
17. [Clinical efficacy of a standardized specific immunotherapy against house dust mite in 85 asthmatic children].
Zhang X; Li MR; Wang C; Wang XN; Zhang HL; Lin J; Jin K; Li YC
Zhonghua Er Ke Za Zhi; 2010 Jul; 48(7):526-30. PubMed ID: 21055090
[TBL] [Abstract][Full Text] [Related]
18. Eczematous skin reaction to atopy patch testing with cockroach in patients with atopic dermatitis.
Michel S; Yawalkar N; Schnyder B; Fischer B; Helbling A
J Investig Allergol Clin Immunol; 2009; 19(3):173-9. PubMed ID: 19610259
[TBL] [Abstract][Full Text] [Related]
19. Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures.
Pham-Thi N; Scheinmann P; Fadel R; Combebias A; Andre C
Pediatr Allergy Immunol; 2007 Feb; 18(1):47-57. PubMed ID: 17295799
[TBL] [Abstract][Full Text] [Related]
20. CC chemokines as potential immunologic markers correlated with clinical improvement of atopic dermatitis patients by immunotherapy.
Kwon YS; Oh SH; Wu WH; Bae BG; Lee HJ; Lee MG; Lee KH
Exp Dermatol; 2010 Mar; 19(3):246-51. PubMed ID: 19758316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]